Ultragenyx Pharmaceutical
(NASDAQ:RARE)
$62.65
2.99[5.01%]
At close: Jul 1
$62.65
00
After Hours: 4:30PM EDT
Day High/Low58.65 - 63.28
52 Week High/Low45.2 - 104.38
Open / Close59.84 / 62.65
Float / Outstanding55.1M / 69.9M
Vol / Avg.455.3K / 567K
Mkt Cap4.4B
P/E-
50d Avg. Price56.21
Div / Yield-
Payout Ratio-
EPS-2.19
Total Float55.1M

Ultragenyx Pharmaceutical (NASDAQ:RARE), Quotes and News Summary

Ultragenyx Pharmaceutical (NASDAQ: RARE)

Day High/Low58.65 - 63.28
52 Week High/Low45.2 - 104.38
Open / Close59.84 / 62.65
Float / Outstanding55.1M / 69.9M
Vol / Avg.455.3K / 567K
Mkt Cap4.4B
P/E-
50d Avg. Price56.21
Div / Yield-
Payout Ratio-
EPS-2.19
Total Float55.1M
load more
Sector: Health Care.Industry: Biotechnology
Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-01
REV
Q1 2022Est.ActualSurprise
EPS-1.760-2.190 -0.4300
REV83.650M79.935M-3.715M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Ultragenyx Pharmaceutical Questions & Answers

Q
How do I buy Ultragenyx Pharmaceutical (RARE) stock?
A

You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ: RARE) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Ultragenyx Pharmaceutical's (RARE) competitors?
Q
What is the target price for Ultragenyx Pharmaceutical (RARE) stock?
A

The latest price target for Ultragenyx Pharmaceutical (NASDAQ: RARE) was reported by Stifel on Friday, July 1, 2022. The analyst firm set a price target for 142.00 expecting RARE to rise to within 12 months (a possible 126.66% upside). 15 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Ultragenyx Pharmaceutical (RARE)?
A

The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $62.65 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Ultragenyx Pharmaceutical (RARE) pay a dividend?
A

There are no upcoming dividends for Ultragenyx Pharmaceutical.

Q
When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?
A

Ultragenyx Pharmaceutical’s Q2 earnings are confirmed for Monday, August 1, 2022.

Q
Is Ultragenyx Pharmaceutical (RARE) going to split?
A

There is no upcoming split for Ultragenyx Pharmaceutical.

Q
What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?
A

Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.